Cite
HARVARD Citation
Prundean, A. et al. (2015). A phase II, open‐label evaluation of cysteamine tolerability in patients with Huntington's disease. Movement disorders. 30 (2), pp. 288-289. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Prundean, A. et al. (2015). A phase II, open‐label evaluation of cysteamine tolerability in patients with Huntington's disease. Movement disorders. 30 (2), pp. 288-289. [Online].